 |
인쇄하기
취소
|
Phase II study of Dong-A's new impotence drug successful.
Dong-A (President: Kang Moon-seok) announced that the phase II clinical study for DA8159, an oral impotence drug, had been successfully completed against the total 319 patients in 9 month trial.
According to the phase II clinical studies performed for impotence patients at 13 general hospitals under the double blind, DA8159 showed a significant improvement after 12 weeks treatment compared t...
According to the phase II clinical studies performed for impotence patients at 13 general hospitals under the double blind, DA8159 showed a significant improvement after 12 weeks treatment compared t...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.